Metastatic cancer cells generally cannot be eradicated using traditional surgical or
chemoradiotherapeutic strategies, and disease recurrence is extremely common following …

Stem cell-based therapies are emerging as a promising strategy to tackle cancer. Multiple
stem cell types have been shown to exhibit inherent tropism towards tumours. Moreover …

Insect-derived baculoviruses have emerged as versatile and safe workhorses of
biotechnology. Baculovirus expression vectors (BEVs) have been applied widely for crop …

There is great promise that ongoing advances in the delivery of therapeutics to the central
nervous system (CNS) combined with rapidly expanding knowledge of brain tumor patho …

Current cancer treatments may create profound iatrogenic outcomes. The adverse effects of
these treatments still remain, as the serious problems that practicing physicians have to …

Tumorigenesis is an important problem that needs to be addressed in the field of human
stem/progenitor cell transplantation for the treatment of subacute spinal cord injury (SCI) …

Glioblastoma (GBM) is the most aggressive form of brain cancer, with a dismal prognosis
and extremely low percentage of survivors. Novel therapies are in dire need to improve the …

Personalized medicine is a new approach toward safer and even cheaper treatments with
minimal side effects and toxicity. Planning a therapy based on individual properties causes …

Advances in understanding adult stem cell biology have facilitated the development of novel
cell-based therapies for cancer. Recent developments in conventional therapies (eg, tumor …

Cancers of the brain remain one of the greatest medical challenges. Traditional surgery and
chemo-radiation therapy are unable to eradicate diffuse cancer cells and tumor recurrence …